A closer look: the benefits and effectiveness of cognitive behavioral therapy on a female-specific unit for treatment of bipolar disorder.
This case study examines the benefits and effectiveness of Cognitive Behavioral Therapy (CBT) and a female-specific unit for a woman with Bipolar Disorder. For this case study, the patient, Sonia, is a pseudonym for reasons of confidentiality. Sonia has been persistently non-compliant with her psychotropic medications since being diagnosed with Bipolar Disorder. Throughout her life, she has maintained the distortion that she does not need her prescribed psychotropic medications. This thinking has served as a catalyst for Sonia to stop taking her prescribed psychotropic medications and ultimately relapse, which has resulted in approximately 20 psychiatric hospitalizations. Another intervention, in addition to psychotropic medications, was desperately needed to stop this vicious cycle, in order to address her negative conceptualization of her illness. During her last hospitalization on a specialized psychiatric inpatient program for women, Sonia received Cognitive Behavioral Therapy from a therapist in training at the Beck Institute for Cognitive Therapy. The combination of CBT, re-stabilization on psychotropic medications, and a female-specific unit led to an excellent outcome for Sonia.
Rodriguez
Lisette J
LJ
NewYork-Presbyterian Hospital, New York, NY 10605, USA. ljr9002@nyp.org
D000328:Adult; D001714:Bipolar Disorder / Q000523:psychology / Q000628:therapy*; D015928:Cognitive Behavioral Therapy / Q000458:organization & administration*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006301:Health Services Needs and Demand; D006630:Hispanic or Latino / Q000193:education / Q000523:psychology; D006757:Hospital Units / Q000458:organization & administration*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D009518:New York; D010353:Patient Education as Topic; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012008:Recurrence; D013850:Thinking; D016896:Treatment Outcome; D016312:Treatment Refusal / Q000523:psychology*; D014635:Valproic Acid / Q000627:therapeutic use; D014930:Women / Q000193:education / Q000523:psychology*; D014932:Women's Health Services / Q000458:organization & administration*
D011619:Psychotropic Drugs; D014635:Valproic Acid; D008140:Lorazepam